Article Text
Abstract
Objective Delegates at the Outcome Measures in Rheumatology (OMERACT) 10 conference (Borneo, 4–8 May 2010) questioned how the new seven-domain Rheumatoid Arthritis Impact of Disease (RAID) score performs as a global measure. Score distributions and associations between the RAID score and patient-reported outcomes (PROs) and demographic variables were examined in a large sample of rheumatoid arthritis (RA) patients.
Methods 1086 patients in the Oslo RA Register responded to a postal survey with commonly used PROs. Bivariate associations between the RAID score and other measures are reported as Pearson correlation coefficients.
Results The mean RAID was 3.37±2.17. The distribution of the RAID score showed a slight floor effect: 17.5% had a score between 0 and 1, and 14.4% between 1 and 2, whereas only 1.0% and 0.3% had scores between 8 and 9, and 9 and 10, respectively. Correlations between the RAID score and the patient global assessment, Rheumatoid Arthritis Disease Activity Index, Short-Form (SF)-6D and EQ-5D were 0.82, 0.82, −0.77 and −0.73, respectively. Strong correlation was also seen between RAID and pain, the domain with highest weight, whereas correlations to measures of other RAID domains were moderate. The RAID score was higher in women than men (3.49 vs 2.95, p=0.001).
Conclusion The RAID score was correlated more strongly to other global measures than to PROs, reflecting single health domains.
Statistics from Altmetric.com
Footnotes
-
Patient consent Obtained.
-
Ethics approval This study was conducted with the approval of the South-Eastern Regional Committee for Research Ethics in Medicine and Health.
-
Competing interests Professor Johannes Bijlsma was the handling Editor
-
Provenance and peer review Not commissioned; externally peer reviewed.